Selected article for: "chronic lung disease and healthy control"

Author: Ademhan Tural, Dilber; Emiralioglu, Nagehan; Tural Hesapcioglu, Selma; Karahan, Sevilay; Ozsezen, Beste; Sunman, Birce; Nayir Buyuksahin, Halime; Yalcin, Ebru; Dogru, Deniz; Ozcelik, Ugur; Kiper, Nural
Title: Psychiatric and general health effects of COVID‐19 pandemic on children with chronic lung disease and parents' coping styles
  • Cord-id: ds5xpqu3
  • Document date: 2020_9_28
  • ID: ds5xpqu3
    Snippet: BACKGROUND: We aim to assess the anxiety and depressive symptoms related to the COVID‐19 pandemic in children with chronic lung disease and their parents and also to evaluate parents' coping strategies. METHODS: Parents of children aged 4–18 years, with chronic lung disease (study group n = 113) and healthy control (n = 108) were enrolled in the study. General Health Questionnaire‐12, specific COVID‐19 related anxiety questions, The Coping Orientation to Problems Experienced inventory, c
    Document: BACKGROUND: We aim to assess the anxiety and depressive symptoms related to the COVID‐19 pandemic in children with chronic lung disease and their parents and also to evaluate parents' coping strategies. METHODS: Parents of children aged 4–18 years, with chronic lung disease (study group n = 113) and healthy control (n = 108) were enrolled in the study. General Health Questionnaire‐12, specific COVID‐19 related anxiety questions, The Coping Orientation to Problems Experienced inventory, coronavirus‐related psychiatric symptom scale in children–parental form were used to analyze the psychiatric effects of COVID‐19. Parents were also asked about how online education affected their family life and children. All data were compared between children/parents in the study and control groups. Risk factors related with anxiety scores of children were also analyzed. RESULTS: Talking about the pandemic, concern about coronavirus transmission, taking precaution to prevent coronavirus transmission, making pressure to protect from COVID‐19 were significantly higher in parents within the study group (p < .05). Parents in the study group used more problem‐focused coping than parents in the control group (p = .003). Anxiety symptoms score was higher in children of the study group (p = .007). Parents in the study group found online education more useful than parents in the control group. CONCLUSION: Children with chronic lung diseases and their parents have more anxiety due to COVID‐19 pandemic and these parents use more mature coping strategies to manage the stress of the pandemic. Longitudinal and larger studies should be done in all aspects of online education in children with chronic lung diseases.

    Search related documents:
    Co phrase search for related documents
    • acceptance significantly and acute sars cov respiratory syndrome coronavirus: 1
    • acute sars cov respiratory syndrome coronavirus and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and low respiratory tract: 1, 2, 3, 4, 5
    • acute sars cov respiratory syndrome coronavirus and lung biopsy: 1, 2, 3, 4, 5
    • acute sars cov respiratory syndrome coronavirus and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and lung damage cause: 1, 2, 3
    • acute sars cov respiratory syndrome coronavirus and lung destruction: 1
    • acute sars cov respiratory syndrome coronavirus and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • low respiratory and lung biopsy: 1
    • low respiratory and lung damage: 1, 2, 3
    • low respiratory and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • low respiratory and lung function: 1, 2, 3
    • low respiratory tract and lung disease: 1, 2, 3